Get the Stockscreener App
30.20
3.35%
0.98
Pre-market:
29.90
-0.30
-0.99%
Xoma Royalty Corp stock is traded at $30.20, with a volume of 100.85K.
It is up +3.35% in the last 24 hours and up +12.94% over the past month.
XOMA Royalty Corp is a biotechnology royalty aggregator playing a role in helping biotech companies achieve their goal of improving human health. XOMA acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceuticals or biotechnology companies. XOMA acquires future economic rights, the seller receives non-dilutive, non-recourse funding that can use to advance their internal drug candidate(s) or for general corporate purposes. Geographically, the company operates in Switzerland, United States, Asia Pacific, Europe and Others.
See More
Previous Close:
$29.22
Open:
$29.36
24h Volume:
100.85K
Relative Volume:
0.27
Market Cap:
$359.55M
Revenue:
$47.11M
Net Income/Loss:
$15.64M
P/E Ratio:
40.51
EPS:
0.7455
Net Cash Flow:
$-15.89M
1W Performance:
+10.42%
1M Performance:
+12.94%
6M Performance:
-15.43%
1Y Performance:
+45.61%
1-Day Range:
$29.36
$30.95
1-Week Range:
$27.58
$30.95
52-Week Range:
$18.35
$39.92
Xoma Royalty Corp Stock (XOMA) Company Profile
Name
Xoma Royalty Corp
Sector
Industry
Phone
510-204-7239
Address
2200 POWELL STREET, EMERYVILLE, CA
Compare XOMA vs VRTX, REGN, ALNY, ARGX, INSM
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
XOMA
Xoma Royalty Corp
|
30.20 | 347.88M | 47.11M | 15.64M | -15.89M | 0.7455 |
VRTX
Vertex Pharmaceuticals Inc
|
454.97 | 115.58B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
749.47 | 79.23B | 14.34B | 4.50B | 3.77B | 41.56 |
ALNY
Alnylam Pharmaceuticals Inc
|
328.70 | 43.59B | 3.71B | 313.75M | 465.38M | 2.2571 |
ARGX
Argen X Se Adr
|
697.05 | 43.26B | 4.16B | 1.29B | 734.26M | 19.58 |
INSM
Insmed Inc
|
148.31 | 31.97B | 606.42M | -1.28B | -997.58M | -6.403 |
Xoma Royalty Corp Stock (XOMA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-17-25 | Initiated | The Benchmark Company | Buy |
| Apr-29-24 | Initiated | Leerink Partners | Outperform |
| Sep-07-21 | Downgrade | Wedbush | Outperform → Neutral |
| Jun-29-21 | Initiated | Aegis Capital | Buy |
| Jan-19-21 | Reiterated | H.C. Wainwright | Buy |
| Jan-18-18 | Reiterated | H.C. Wainwright | Buy |
| Oct-17-17 | Resumed | H.C. Wainwright | Buy |
| Sep-05-17 | Upgrade | Wedbush | Neutral → Outperform |
| Jun-12-17 | Initiated | H.C. Wainwright | Buy |
| Nov-14-16 | Downgrade | Wedbush | Outperform → Neutral |
| Mar-11-16 | Reiterated | Wedbush | Outperform |
| Jul-23-15 | Downgrade | Jefferies | Buy → Hold |
| Jul-22-15 | Downgrade | Ladenburg Thalmann | Buy → Neutral |
| Jul-22-15 | Downgrade | Piper Jaffray | Overweight → Neutral |
| Oct-10-14 | Resumed | ROTH Capital | Buy |
| Apr-29-14 | Upgrade | MLV & Co | Hold → Buy |
| Mar-11-14 | Downgrade | MLV & Co | Buy → Hold |
| Mar-05-14 | Reiterated | Ladenburg Thalmann | Buy |
| Oct-31-13 | Reiterated | MLV & Co | Buy |
| May-09-13 | Reiterated | Ladenburg Thalmann | Buy |
| May-14-12 | Initiated | Cowen & Co | Outperform |
| Mar-31-11 | Reiterated | MLV Capital | Buy |
| Mar-23-11 | Reiterated | RBC Capital Mkts | Outperform |
| Jan-06-11 | Reiterated | Ladenburg Thalmann | Buy |
| Jan-04-11 | Reiterated | Wedbush | Outperform |
View All
Xoma Royalty Corp Stock (XOMA) Latest News
Bear Alert: What drives XOMA Royalty Corporations stock priceWeekly Profit Analysis & Technical Pattern Based Buy Signals - baoquankhu1.vn
XOMA Corp8.375% DP PFD B declares $0.5234 dividend - MSN
XOMA Royalty Corporation (NASDAQ:XOMA) Receives Consensus Rating of "Hold" from Analysts - MarketBeat
XOMA shares climb after Q4 results top forecasts on strong royalty income - MSN
XOMA Royalty's (XOMA) "Buy" Rating Reaffirmed at HC Wainwright - MarketBeat
XOMA Royalty (NASDAQ:XOMA) Issues Quarterly Earnings Results, Beats Expectations By $0.16 EPS - MarketBeat
XOMA Q1 2026 slides: royalty receipts surge 68%, portfolio tops 120 assets - Investing.com Australia
XOMA Royalty Corp 2025 Annual Report: Financials, Nasdaq Listings, and Key Agreements (10-K Filing) - Minichart
XOMA Royalty Q4 Earnings Call Highlights - MarketBeat
XOMA Royalty Declares Quarterly Preferred Stock Dividends - The Manila Times
XOMA Royalty Corporation (XOMA) Q4 2025 Earnings Call Transcript Summary - 富途牛牛
Xoma Royalty 2025 10-K: $52.1M Revenue, $31.7M Net Income - TradingView
XOMA Royalty (NASDAQ: XOMA) grows 2025 royalty cash flow and expands deals - Stock Titan
XOMA Royalty Reports Strong 2025 Financial Results, Expands Portfolio and Anticipates Key 2026 Pipeline Events - Minichart
Earnings call transcript: XOMA Q4 2025 earnings beat boosts stock By Investing.com - Investing.com Canada
Earnings call transcript: XOMA Q4 2025 earnings beat boosts stock - Investing.com
XOMA Royalty Jumps After Q4 Double Beat, Signals Pipeline Catalysts Ahead - Benzinga
XOMA shares jump 7% as strong royalty receipts drive Q4 earnings, revenue beat By Investing.com - Investing.com South Africa
XOMA shares jump 7% as strong royalty receipts drive Q4 earnings, revenue beat - Investing.com
XOMA Royalty (NASDAQ: XOMA) swings to 2025 profit as royalties and milestones surge - Stock Titan
XOMA Royalty Corporation Reports Strong Financial Results and Strategic Developments for Full Year 2025 - Quiver Quantitative
XOMA Royalty Reports 2025 Financial Results and Highlights Recent Business Achievements - Stock Titan
XOMA Royalty Q4 2025 Earnings Call Transcript - MarketBeat
XOMA (XOMA) CEO granted 126,813 performance units and new RSUs - Stock Titan
XOMA (XOMA) CIO receives stock, PSU grants and updates holdings - Stock Titan
CFO at XOMA (XOMA) receives 138,462 PSUs and 90,000 RSUs - Stock Titan
Equity awards for XOMA (XOMA) Chief Legal Officer include RSUs and PSUs - Stock Titan
Aug Retail: Why is XOMA Royalty Corporation stock going downQuarterly Market Summary & Reliable Price Breakout Alerts - baoquankhu1.vn
XOMA Royalty Corporation EFFE Depositary Shares Representing 1/1000th Perpetual Preferred Stock (XOMAO.US) will release its earnings report before the market opens on March 18. - 富途牛牛
FMR LLC's Strategic Acquisition of XOMA Royalty Corp Shares - GuruFocus
XOMA Royalty (NASDAQ:XOMA) Downgraded to Strong Sell Rating by Zacks Research - MarketBeat
XOMA Royalty to Report Fourth Quarter and Full Year 2025 Financial Results on March 18, 2026 - The Manila Times
XOMA Royalty sets March 18 webcast on 2025 financial results - Stock Titan
XOMA Royalty (XOMA) to Release Earnings on Monday - MarketBeat
XOMA|XOMA Royalty Corp|Price:25.980|Chg%:-0.33 - TradingKey
FMR LLC holds 10.2% of XOMA Royalty (XOMA) after Schedule 13G/A amendment - Stock Titan
Layoff Watch: Why is XOMA Royalty Corporation stock going downJuly 2025 WrapUp & Precise Swing Trade Alerts - baoquankhu1.vn
XOMA Royalty Corporation (NASDAQ:XOMA) Short Interest Update - MarketBeat
XOMA (NASDAQ: XOMA) details 2025 royalty cash, buybacks and litigation costs - Stock Titan
LVTX Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
XOMA Royalty Corporation (NASDAQ:XOMA) Receives $60.60 Average Price Target from Brokerages - Defense World
What Analysts Are Saying About XOMA Royalty Stock - Sahm
Leerink raises Xoma stock price target on royalty outlook - Investing.com
XOMA Royalty Corporation (NASDAQ:XOMA) Receives Average Recommendation of "Moderate Buy" from Analysts - MarketBeat
MURAMural Oncology PLC Latest Stock News & Market Updates - Stock Titan
XOMA Royalty to Present at Investor Conferences in March - 富途牛牛
Turnstone Biologics Corp. Enters into Agreement to be Acquired by XOMA Royalty Corporation for $0.34 in Cash Per Share Plus a Contingent Value Right - Intellectia AI
Biotech royalty player XOMA lines up March investor talks - Stock Titan
Short Interest in XOMA Royalty Corporation (NASDAQ:XOMA) Grows By 27.4% - MarketBeat
What drives XOMA Royalty Corporation’s stock priceJuly 2025 Gainers & Smart Swing Trading Alerts - mfd.ru
XOMA Royalty (NASDAQ:XOMA) Upgraded by TD Cowen to "Hold" Rating - MarketBeat
Xoma Royalty Corp Stock (XOMA) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.82%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):